Half-year report · Q2
6323.TEDINET S100WUQU
Period2025-03-01 → 2025-08-31
Filed2025-10-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥65.6bn | 2025-03-01 → 2025-08-31 | Cons. | Net sales |
| Revenue | ¥124.4bn | 2024-03-01 → 2025-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥60.2bn | 2024-03-01 → 2024-08-31 | Cons. | Net sales |
| Operating income | ¥16.2bn | 2025-03-01 → 2025-08-31 | Cons. | Operating income |
| Operating income | ¥17.1bn | 2024-03-01 → 2024-08-31 | Cons. | Operating income |
| Ordinary income | ¥14.6bn | 2025-03-01 → 2025-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥35.5bn | 2024-03-01 → 2025-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥20.6bn | 2024-03-01 → 2024-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥14.6bn | 2025-03-01 → 2025-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥20.6bn | 2024-03-01 → 2024-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥10.9bn | 2025-03-01 → 2025-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥23.6bn | 2024-03-01 → 2025-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥15.8bn | 2024-03-01 → 2024-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥10.2bn | 2025-03-01 → 2025-08-31 | Cons. | Profit loss |
| Net income | ¥16.2bn | 2024-03-01 → 2024-08-31 | Cons. | Profit loss |
| Total assets | ¥177.9bn | at 2025-08-31 | Cons. | Assets |
| Total assets | ¥187.7bn | at 2025-02-28 | Cons. | Assets |
| Total assets | ¥184.7bn | at 2024-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥51.4bn | at 2025-08-31 | Cons. | Liabilities |
| Total liabilities | ¥59.0bn | at 2025-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥126.5bn | at 2025-08-31 | Cons. | Net assets |
| Net assets / equity | ¥128.7bn | at 2025-02-28 | Cons. | Net assets |
| Net assets / equity | ¥124.2bn | at 2024-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥61.0bn | at 2025-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥63.0bn | at 2025-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥61.0bn | at 2025-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥61.3bn | at 2025-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥54.9bn | at 2024-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥38.0bn | at 2024-02-29v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥12.9bn | 2025-03-01 → 2025-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥36.8bn | 2024-03-01 → 2025-02-28 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥20.1bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥471m | 2025-03-01 → 2025-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥6.5bn | 2024-03-01 → 2025-02-28 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.7bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥12.7bn | 2025-03-01 → 2025-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥9.2bn | 2024-03-01 → 2025-02-28 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.2bn | 2024-03-01 → 2024-08-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥62.13 | 2025-03-01 → 2025-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥134.08 | 2024-03-01 → 2025-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.97 | 2024-03-01 → 2024-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥62.12 | 2025-03-01 → 2025-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥133.99 | 2024-03-01 → 2025-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥89.85 | 2024-03-01 → 2024-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 65.6% | at 2025-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.8% | at 2025-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.6% | at 2024-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-03-01 → 2025-08-31 | −¥57m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-03-01 → 2025-08-31 | −¥57m |
| Reconciling Itemsreconciling | segment profit | 2025-03-01 → 2025-08-31 | −¥427m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue | 2025-03-01 → 2025-08-31 | ¥366m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue external | 2025-03-01 → 2025-08-31 | ¥366m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | segment profit | 2025-03-01 → 2025-08-31 | −¥119m |
| jpcrp040300-q2r_E02328-000Semiconductor And Flat Panel Displayreportable segment | revenue | 2025-03-01 → 2025-08-31 | ¥65.3bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Flat Panel Displayreportable segment | revenue external | 2025-03-01 → 2025-08-31 | ¥65.2bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Flat Panel Displayreportable segment | revenue intersegment | 2025-03-01 → 2025-08-31 | ¥57m |
| jpcrp040300-q2r_E02328-000Semiconductor And Flat Panel Displayreportable segment | segment profit | 2025-03-01 → 2025-08-31 | ¥16.8bn |
| —segment total | revenue | 2025-03-01 → 2025-08-31 | ¥65.7bn |
| —segment total | revenue external | 2025-03-01 → 2025-08-31 | ¥65.6bn |
| —segment total | revenue intersegment | 2025-03-01 → 2025-08-31 | ¥57m |
| —segment total | segment profit | 2025-03-01 → 2025-08-31 | ¥16.6bn |
| Reconciling Itemsreconciling | revenue | 2024-03-01 → 2024-08-31 | −¥108m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-03-01 → 2024-08-31 | −¥108m |
| Reconciling Itemsreconciling | segment profit | 2024-03-01 → 2024-08-31 | −¥410m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue | 2024-03-01 → 2024-08-31 | ¥334m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | revenue external | 2024-03-01 → 2024-08-31 | ¥334m |
| jpcrp040300-q2r_E02328-000Life Sciencereportable segment | segment profit | 2024-03-01 → 2024-08-31 | −¥52m |
| jpcrp040300-q2r_E02328-000Semiconductor And Flat Panel Displayreportable segment | revenue | 2024-03-01 → 2024-08-31 | ¥60.0bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Flat Panel Displayreportable segment | revenue external | 2024-03-01 → 2024-08-31 | ¥59.9bn |
| jpcrp040300-q2r_E02328-000Semiconductor And Flat Panel Displayreportable segment | revenue intersegment | 2024-03-01 → 2024-08-31 | ¥108m |
| jpcrp040300-q2r_E02328-000Semiconductor And Flat Panel Displayreportable segment | segment profit | 2024-03-01 → 2024-08-31 | ¥17.6bn |
| —segment total | revenue | 2024-03-01 → 2024-08-31 | ¥60.3bn |
| —segment total | revenue external | 2024-03-01 → 2024-08-31 | ¥60.2bn |
| —segment total | revenue intersegment | 2024-03-01 → 2024-08-31 | ¥108m |
| —segment total | segment profit | 2024-03-01 → 2024-08-31 | ¥17.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 532
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in financing activities | Prior1YTDDuration | -3195000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -12745000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 2717000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -973000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 16962000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -379000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 37951000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 61330000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 54913000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 60951000000 | JPY |
| Directors compensations sga | Prior1YTDDuration | 316000000 | JPY |
| Directors compensations sga | CurrentYTDDuration | 481000000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 1324000000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 2238000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 524000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 571000000 | JPY |
| Provision for directors bonuses sga | Prior1YTDDuration | -2000000 | JPY |
| Provision for directors bonuses sga | CurrentYTDDuration | 9000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 49000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 78000000 | JPY |
| Provision for directors retirement benefits sga | Prior1YTDDuration | 10000000 | JPY |
| Provision for directors retirement benefits sga | CurrentYTDDuration | 7000000 | JPY |
| Commission fee sga | Prior1YTDDuration | 661000000 | JPY |
| Commission fee sga | CurrentYTDDuration | 907000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 562000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 737000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | 71000000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | 35000000 | JPY |
| Amortization of goodwill sga | Prior1YTDDuration | 128000000 | JPY |
| Amortization of goodwill sga | CurrentYTDDuration | 1545000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndFlatPanelDisplayReportableSegmentMember | 59895000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentMember | 334000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 60229000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 60229000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndFlatPanelDisplayReportableSegmentMember | 108000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 108000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -108000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndFlatPanelDisplayReportableSegmentMember | 60003000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentMember | 334000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 60337000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -108000000 | JPY |
| Net sales | Prior1YTDDuration | 60229000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02328-000SemiconductorAndFlatPanelDisplayReportableSegmentMember | 17609000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02328-000LifeScienceReportableSegmentMember | -52000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 17556000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -410000000 | JPY |
| Operating income | Prior1YTDDuration | 17146000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |